Departments of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina; Departments of Otolaryngology-Head and Neck Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina.
Departments of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
J Voice. 2020 Jul;34(4):636-644. doi: 10.1016/j.jvoice.2019.02.010. Epub 2019 Mar 14.
To determine the effects of globus pallidus interna (GPi) deep brain stimulation (DBS) on speech and voice quality of patients with primary, medically refractory dystonia.
Voices of 14 patients aged ≥18 years (males = 7 and females = 7) with primary dystonia (DYT1 gene mutation dystonia = 4, cervical dystonia = 6, and generalized dystonia = 4) with bilateral GPi DBS were assessed. Five blinded raters (two fellowship-trained laryngologists and three speech/language pathologists) evaluated audio recordings of each patient pre- and post-DBS. Perceptual voice quality was rated using the Grade, Roughness, Breathiness, Asthenia, and Strain scale and changes in speech intelligibility were assessed with the Clinical Global Impression scale of Severity instrument. Inter-rater and intrarater reliability rates for perceptual voice ratings were assessed using the kappa coefficient.
Voice quality parameters showed mean improvements in Grade (P < 0.0001), Roughness (P = 0.0043), and Strain (P < 0.0001) 12 months post-DBS. Asthenia increased from baseline to 6 months (P = 0.0022) and declined significantly from 6 to 12 months (P = 0.0170). Breathiness did not change significantly over time. Speech intelligibility also improved from 6 to 12 months (P = 0.0202) and from pre-DBS to 12 months post-DBS (P = 0.0022). Grade and Strain ratings had nearly perfect and substantial inter-rater agreement (0.84 and 0.71, respectively).
Voice and speech intelligibility improved after bilateral GPi DBS for dystonia. GPi DBS may emerge as a potential treatment option for patients with medically refractory laryngeal dystonia.
确定苍白球内侧(GPi)深部脑刺激(DBS)对原发性、药物难治性肌张力障碍患者的言语和嗓音质量的影响。
评估了 14 名年龄≥18 岁的患者(男性 7 名,女性 7 名)的嗓音,这些患者均患有原发性肌张力障碍(DYT1 基因突变性肌张力障碍 4 例,颈肌张力障碍 6 例,全身性肌张力障碍 4 例),并接受了双侧 GPi-DBS 治疗。5 名盲评者(2 名经过 fellowship培训的喉科医生和 3 名言语/语言病理学家)评估了每位患者 DBS 前后的音频记录。使用等级、粗糙度、呼吸音、乏力度和紧张度量表评估感知嗓音质量,并使用临床总体印象严重程度量表评估言语清晰度的变化。使用kappa 系数评估感知嗓音评分的组内和组间可靠性。
DBS 后 12 个月,嗓音质量参数的平均等级(P<0.0001)、粗糙度(P=0.0043)和紧张度(P<0.0001)均有所改善。乏力度从基线到 6 个月时增加(P=0.0022),从 6 个月到 12 个月时显著下降(P=0.0170)。呼吸音在时间上没有明显变化。言语清晰度也从 6 个月到 12 个月(P=0.0202)以及从 DBS 前到 12 个月后(P=0.0022)有所改善。等级和紧张度评分具有近乎完美和实质性的组内一致性(分别为 0.84 和 0.71)。
双侧 GPi-DBS 治疗肌张力障碍后,嗓音和言语清晰度得到改善。GPi-DBS 可能成为药物难治性喉肌张力障碍患者的潜在治疗选择。